Mesoblast Limited is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical analysis and clinical research.
The company stated in the following report that they conduct pre-clinical trials of their drugs on animals.
“This is the first study to show that intravenously administered STRO-1/STRO-3 immunoselected MPCs can ameliorate clinical and histopathologic disease severity in a large animal model of collagen induced arthritis, a highly relevant and predictive model of human RA.” (Page 1) Read the following document
Mesoblast Limited provides biomedical services. The Company develops drugs for cardiovascular diseases, oncology, hematology, and spine orthopedic disorders treatment. Mesoblast conducts its business worldwide. [Source: Bloomberg]
Company Website: http://www.mesoblast.com